Home
overview

The Clinical Trials in Cancer conference is one of the leading events to attend to discover the latest thinking in adaptive trial designs, gain insight into cancer biomarkers, understand the challenges of translational medicine and hear case studies on the logistical and operational issues with conducting clinical trials in Europe.

Following the great success of SMi's 7th annual Clinical Trials in Cancer event, we are pleased that the event is back for 2009!

The conference themes will be:

  • Targeted therapy
  • Clinical trial design
  • Multi-national clinical trials
  • Conducting clinical trials in India and Eastern Europe
  • Partnerships in oncology clinical trials
  • Phase I to Phase III clinical trials
  • Successful patient recruitment and retention
  • Operational and logistical challenges in oncology clinical trials
  • Conducting clinical trials in cancer
  • Personalised healthcare
  • Cancer biomarkers
  • Imaging technology in oncology

 

 

  • IMPROVE trial quality through increased design efficiency
  • AVOID project delays by improving patient retention
  • ENSURE regulatory compliance and project integrity in overseas trials

Previous Clinical Trials in Cancer attracted the following delegates:

  • Amgen
  • Genzyme
  • Ferring Pharmaceuticals
  • Merck Serono
  • Johnson & Johnson
  • Boehringer Ingelheim
  • Astra Zeneca
  • Takeda Pharma Europe
  • Charing Cross Hospital
  • Trion Pharma
  • Roche Products
  • Cancer Research UK
  • Glaxo Smith Kline
  • Munipharma
  • King's College  London
  • Glycotype GmbH
  • Scimega Research
  • GeneQuest Diagnostics
  • Spirogen
  • Fulcrum Pharma Developments
  • IMS Health

 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Michael Krams

Michael Krams, Vice President, Adaptive Trials and Applied Program Strategies, Clinical Development, Wyeth Research

9:10 GLOBAL CLINICAL TRIAL DESIGN: THE CHALLENGES

Michael Krams

Michael Krams, Vice President, Adaptive Trials and Applied Program Strategies, Clinical Development, Wyeth Research

  • Best practise design for Phase I to Phase III
  • The process, the people and the logistics
  • Challenges and getting around them
  • What has worked? What needs improving?
  • 9:50 IMAGING TECHNOLOGY IN ONCOLOGY

    Dana Ghiorghiu

    Dana Ghiorghiu, Research Physician - Imaging, Astrazeneca

  • Imaging in cancer treatment
  • Novel techniques & approaches
  • Quantitative analysis
  • Endpoints in imaging
  • 10:30 Morning Coffee

    11:00 LOGISTICAL & OPERATIONAL CHALLENGES IN ONCOLOGY CLINICAL TRIALS

    Ridwaan Jhetam

    Ridwaan Jhetam, Clinical Operations Head: Oncology, J & J Global Clinical Operations

  • Planning and optimisation
  • Operational and logistical challenges and issues encountered?
  • What has worked? What needs improvement?
  • 11:40 THE PATIENT PATHWAY

    Paddy Stevenson

    Paddy Stevenson, NIHR Operations Manager, Newcastle Biomedicine Clinical Research Platforms

  • Demonstrations from experienced practitioner working in the field
  • Case studies from the ward
  • Working toward a successful outcome
  • 12:20 Networking Lunch

    13:50 IMPROVING THE SPEED, QUALITY AND INTEGRATION OF RESEARCH RESULTING IN IMPROVED PATIENT CARE

    Robert Coleman

    Robert Coleman, Professor of Medical Oncology, Weston Park Hospital Trust

  • National strategy to prioritise research within the NHS
  • Impact of the National Cancer Research Network (NCRN) on trials accrual
  • Integration of NCRN with the CLRNs
  • Trials that have made a difference to patient care
  • Future priorities
  • 14:30 CLINICAL TRIALS IN ONCOLOGY: FROM DESIGN TO DECISION-MAKING

    Panteli Theocharous

    Panteli Theocharous, Senior Clinical Project Scientist (Associate Director), J & J Global Clinical Development

  • Project management of clinical trials
  • Team management and leadership
  • Problem solving & addressing challenges
  • From design onto practise?
     
  • 15:10 CONDUCTING CLINICAL TRIALS IN INDIA

    Raghib Ali

    Raghib Ali, Director, INDOX Cancer Research Network

  • Why India?
  • Developing successful partnerships with Pharma, CROs, SMOs and sites in India
  • Integrating India into global clinical trials
  • Practical and ethical challenges
  • Overcoming regulatory hurdles
  • 15:50 Chairman’s Closing Remarks

    16:00 Afternoon Tea and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Mark Rolfe

    Mark Rolfe, Vice President, Oncology Biology, Millennium Pharmaceuticals

    9:10 TRANSLATION OF BASIC SCIENCE INTO CLINICAL TRIALS:

    Carsten Gruellich

    Carsten Gruellich, Attending Physician, Oncologist and Haematologist, German Cancer Research Center (DKFZ)

  • Meeting applicable regulations and operating standards
  • The challenges associated
  • Improvements and developments necessary
     
  • 9:50 ADAPTIVE AND SEAMLESS DESIGNS FOR LATE STAGE ONCOLOGY TRIALS

    Yannis Jemiai

    Yannis Jemiai, Associate Director of Biostatistics, Cytel

  • Seamless phase 2 / 3 trials - what are the opportunities and challenges?
  • Re-estimating sample size and events for survival endpoints
  • Determining efficacy and futility stopping rules in cancer trials
  • 10:30 Morning Coffee

    11:00 TRANSITIONING A NOVEL FIRST-IN-CLASS ANTI-CANCER THERAPEUTIC FROM PRE-CLINICAL TO PHASE I TRIALS

    Mark Rolfe

    Mark Rolfe, Vice President, Oncology Biology, Millennium Pharmaceuticals

  • Pre-clinical target selection and validation
  • Cell based mechanism of action biomarkers
  • Building the PK/PD/efficacy relationship
  • Strategies for assaying target, pathway and molecular outcome in human tissue
  • Early clinical experience
  • 11:40 BAYESIAN DOSE-ESCALATION - A THINKING MAN'S DESIGN

    Jyotirmoy Dey

    Jyotirmoy Dey, Biostatistician, Oncology Early Clinical Development, Novartis

  • Who wants Bayesian methods for dose-escalation?
  • What are it's advantages and who benefits from it?
  • How is it implemented?
  • What do we mean by flexibility?
  • What are the challenges?
  • What next?

     

  • 12:20 Networking Lunch

    13:50 HUMAN TISSUE SUPPORTING CANCER DRUG DISCOVERY

    Christopher Womack

    Christopher Womack, Principal Clinical Histopathologist, AstraZeneca

  • Human tissue in the drug discovery process
  • Applying the information to clinical trials
  • Perspectives from user & supplier
  • 14:30 PHASE III PAEDIATRIC ONCOLOGY TRIALS

    Chris Mitchell

    Chris Mitchell, Paediatric Haematology-Oncology, John Radcliffe Hospital

  • Difficulties encountered with paediatric clinical trials
  • Transitioning from phase I/II to phase III trials
  • Developing effective trials taking these issues into account
  • 15:10 Chairman’s Closing Remarks

    15:30 Afternoon Tea and Close of Conference

    +

    Workshops

    Early Phase Oncology Trial Design
    Workshop

    Early Phase Oncology Trial Design

    Copthorne Tara Hotel
    30th June 2009
    London, United Kingdom

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.